Medication for Addiction Treatment During COVID-19
As overdose rates rise, we need addiction treatment in hospitals now more than ever. This guidance outlines how to implement medication for addiction treatment (MAT) during predicted COVID-19 surges.
New HHS Practice Guidelines
Here’s the most important takeaway of the “HHS Practice Guidelines for the Administration of Buprenorphine for Treating Opioid Use Disorder”: All prescribers with a valid state license and DEA can register for an X wavier without mandatory training.
Blueprint for Hospital Opioid Use Disorder Treatment
This comprehensive resource is scalable for any health system, based on our model implemented at diverse sites that demonstrate feasibility at large and small, public and private, urban, and rural hospitals.
Navigator Focused Series
20 Jan 2022, 11:00 am
Engaging special populations- Part I Tribal Health
The Navigator focused series a deep dive into trending topics for all navigators. These one-hour sessions will provide a comprehensive and extensive review of topics such as engaging special populations, racial equity, patient advocacy, alcohol, and other use disorders, and mental health. Leading experts in their field will lead the discussion and provide up-to-date information.